World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
52
Citations
15517
World Ranking
4025
National Ranking
1839

Overview

Robert H. Collins is affiliated with The University of Texas Southwestern Medical Center in the United States. Their research primarily spans the field of Medicine, with a particular focus on Hematology, Genetics, Molecular Biology, Oncology, and Immunology. This multidisciplinary approach supports investigations into various blood disorders and cancer-related conditions.

The scientist's recent publications address critical topics in leukemia and myeloid malignancies. Notable papers include:

  • Integrative analysis of drug response and clinical outcome in acute myeloid leukemia, 2022, Cancer Cell
  • Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial, 2020, Nature Medicine
  • Enasidenib in patients with mutant IDH2 myelodysplastic syndromes: a phase 1 subgroup analysis of the multicentre, AG221-C-001 trial, 2020, The Lancet Haematology
  • Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML, 2021, Blood
  • Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology, 2024, Journal of the National Comprehensive Cancer Network

Robert H. Collins frequently collaborates with other researchers, including:

  • Yazan F. Madanat
  • Stephen S. Chung
  • Prapti A. Patel
  • Farrukh T. Awan
  • Gurbakhash Kaur

The scientist has contributed extensively to multiple publication venues, reflecting their active role in the hematology and oncology research communities. Key journals featuring their work include:

  • Blood
  • Transplantation and Cellular Therapy
  • Clinical Lymphoma Myeloma & Leukemia
  • Journal of Clinical Oncology
  • Leukemia Research

Their research topics cover a broad spectrum within hematologic malignancies and related therapies. Main topics include:

  • Acute Myeloid Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • CAR-T cell therapy research
  • Chronic Lymphocytic Leukemia Research
  • Acute Lymphoblastic Leukemia research

Best Publications

  • Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.

    R H Collins;O Shpilberg;W R Drobyski;D L Porter

  • Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution

    Daniel C Douek;Robert A Vescio;Michael R Betts;Jason M Brenchley

  • Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation

    Kenneth Weinberg;Bruce R. Blazar;Bruce R. Blazar;Bruce R. Blazar;John E. Wagner;John E. Wagner;John E. Wagner;Edward Agura;Edward Agura;Edward Agura

  • Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions.

    David L Porter;Robert H Collins;Ofer Shpilberg;William R Drobyski

  • Prospective Trial of Chemotherapy and Donor Leukocyte Infusions for Relapse of Advanced Myeloid Malignancies After Allogeneic Stem-Cell Transplantation

    John E. Levine;Thomas Braun;Samuel L. Penza;Patrick Beatty

  • A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy

    P. L. Amlot;M. J. Stone;D. Cunningham;J. Fay

  • Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program.

    Hugo Castro-Malaspina;Richard E. Harris;James Gajewski;Norma Ramsay

  • LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration

    Mi Deng;Xun Gui;Jaehyup Kim;Li Xie

  • Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia.

    Viktoras Frismantas;Maria Pamela Dobay;Anna Rinaldi;Joelle Tchinda

  • Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions

    David L. Porter;Robert H. Collins;Christine Hardy;Nancy A. Kernan

  • Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial

    Stefan Faderl;Meir Wetzler;David Rizzieri;Gary Schiller

  • Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial.

    Amy Burd;Ross L. Levine;Amy S. Ruppert;Alice S. Mims

  • Marrow Transplants From Unrelated Donors for Patients With Aplastic Anemia: Minimum Effective Dose of Total Body Irradiation

    H. Joachim Deeg;H. Joachim Deeg;Michael D. Amylon;Richard E. Harris;Robert Collins

  • Prospective Trial of Chemotherapy and Donor Leukocyte Infusions for Relapse of Advanced Myeloid Malignancies After Allogeneic Stem-Cell Transplantation

    Unknown

  • Identification and monitoring of graft-versus-host specific T-cell clone in stem cell transplantation

    Jaroslav Michálek;Robert H Collins;Brenna J Hill;Jason M Brenchley

  • The ITIM-containing receptor LAIR1 is essential for acute myeloid leukaemia development

    Xunlei Kang;Zhigang Lu;Changhao Cui;Changhao Cui;Mi Deng

  • Definitive separation of graft-versus-leukemia- and graft-versus-host-specific CD4+ T cells by virtue of their receptor β loci sequences

    Jaroslav Michalek;Robert H. Collins;Humdum P. Durrani;Petra Vaclavkova

  • Brief report: Donor-derived long-term multilineage hematopoiesis in a liver-transplant recipient

    Robert H. Collins;John Anastasi;Leon W M M Terstappen;Afzal Nikaein

  • Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy.

    H. Joachim Deeg;Kristy Seidel;Jim Casper;Claudio Anasetti

  • Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemia

    Hanna J. Khoury;Robert H. Collins;William Blum;Patrick S. Stiff

  • Graft-versus-Host Disease in a Liver Transplant Recipient

    Robert H. Collins;Barry Cooper;Afzal Nikaein;Goran Klintmalm

  • Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric population

    J. E. Levine;A. J. Barrett;M. J. Zhang;M. Arora

  • Bootstrap Benefit Segmentation as an Experiential Learning Activity

    John A. Schibrowsky;Robert H. Collins;James W. Peltier

  • Elucidating Mechanisms of Acquired Resistance to IDH Inhibition By Saturation Variant Screening of Base-Edited Leukemia Cells

    Junhua Lyu;Yuxuan Liu;Hui Cao;Mingyi Chen

  • The appearance of alloreactive T cell clones correlates withclinical GVHD in patients undergoing allogeneic stem celltransplants

    Jaroslav Michálek;Robert H. Collins;Humdum P. Durrani;Daniel C. Douek

Frequent Co-Authors

Michael R. Betts
Michael R. Betts University of Pennsylvania
Bruce R. Blazar
Bruce R. Blazar University of Minnesota
Richard A. Koup
Richard A. Koup National Institute of Allergy and Infectious Diseases
John E. Wagner
John E. Wagner University of Minnesota
Rolando R. Garcia
Rolando R. Garcia National Center for Atmospheric Research
Kenneth I. Weinberg
Kenneth I. Weinberg Stanford University
Ellen S. Vitetta
Ellen S. Vitetta The University of Texas Southwestern Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can open various career pathways in healthcare and research. Nurses aiming to deepen their expertise might consider transitioning their focus, such as moving from an FNP to ACNP role. This shift allows for specialization in acute care settings, broadening clinical responsibilities and impact. Learn more about making this career move with the fnp to acnp guide.

Accelerated educational programs are particularly valuable for individuals seeking to fast-track their careers. For example, accelerated nurse practitioner programs offer intensive curriculums that prepare students quickly for advanced clinical roles. These programs are well-suited for those looking to enter the workforce without lengthy delays.

For students coming from non-nursing backgrounds, there are online paths tailored to making this transition smoother. The availability of online accelerated nursing programs for non nurses provides a flexible and efficient way to become qualified nurses, opening doors to immunology-related clinical roles.

Additionally, when beginning a nursing career, it's important to find programs with accessibly high acceptance rates. ABSN programs with high acceptance rates offer opportunities for many students to enter the nursing field and eventually specialize in areas like immunology or nurse practitioner roles.

Best Scientists Citing Robert H. Collins

Trending Scientists

Recently Published Articles